Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by OSE Immunotherapeutics SA"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -87.98% vs -30.42% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -29.21% vs -5.33% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.20",
          "val2": "18.30",
          "chgp": "-87.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-25.40",
          "val2": "-20.50",
          "chgp": "-23.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.40",
          "val2": "1.40",
          "chgp": "71.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "1.60",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-23.00",
          "val2": "-17.80",
          "chgp": "-29.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-12,923.20%",
          "val2": "-1,313.40%",
          "chgp": "-1,160.98%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

2.20

18.30

-87.98%

Operating Profit (PBDIT) excl Other Income

-25.40

-20.50

-23.90%

Interest

2.40

1.40

71.43%

Exceptional Items

0.00

1.60

-100.00%

Consolidate Net Profit

-23.00

-17.80

-29.21%

Operating Profit Margin (Excl OI)

-12,923.20%

-1,313.40%

-1,160.98%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is -87.98% vs -30.42% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -29.21% vs -5.33% in Dec 2022

All Annual Results